Fundz

Asgard Therapeutics Appoints Prof Dr Wolfram Brugger as Chief Medical Officer

PRIVATEApr 14, 2026

Position

Chief Medical Officer

Company

Asgard Therapeutics

Dr Wolfram Brugger
LundBiotechnologyFinancial ServicesHealth Care

Description

Asgard Therapeutics announces the appointment of Prof Dr Wolfram Brugger as Chief Medical Officer to lead the advancement of AT-108 into clinical stages. With extensive experience in clinical oncology trials, Brugger joins the team to strengthen its leadership.

Other recent leadership changes in Financial Services and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Asgard Therapeutics, and when

A new leader at Asgard Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Asgard Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Asgard Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Asgard Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Asgard Therapeutics

Location

Lund, Skåne County, Sweden

About

Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen presenting cells. Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard Therapeutics aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Asgard Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Cristiana
Likely contact at this company
••••••••@••••••••

See Cristiana's verified email →

Fabio
Senior decision-maker at this company
••••••••@••••••••

See Fabio's verified email →

Cristiana
Senior decision-maker at this company
••••••••@••••••••

See Cristiana's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Asgard Therapeutics's next move

Learn about Strategic plan

Asgard Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.